Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer

Dawson, Sarah-Jane, Tsui, Dana W.Y., Murtaza, Muhammed, Biggs, Heather, Rueda, Oscar M., Chin, Suet-Feung, Dunning, Mark J., Gale, Davina, Forshew, Tim, Mahler-Araujo, Betania, Rajan, Sabrina, Humphray, Sean, Becq, Jennifer, Halsall, David, Wallis, Matthew, Bentley, David, Caldas, Carlos, Rosenfeld, Nitzan·2013·New England Journal of Medicine

DOI 10.1056/nejmoa1213261

Cited by (1,003)

Items 101–200 of 1,003

Prognostic and predictive impact of circulating tumor DNA in patients with advanced cancers treated with immune checkpoint blockade
Zhang, Qu, Luo, Jia, Wu, Song, Si, Han, Gao, Chen, Xu, Wenjing, Abdullah, Shaad E., Higgs, Brandon W., Dennis, Phillip A., van der Heijden, Michiel S. et al. · 2020 · Cancer Discovery
Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis
Jamie M. J. Weaver, Caryn S. Ross-Innes, Nicholas Brian Shannon, Andy G. Lynch, Tim Forshew, Mariagnese Barbera, Muhammed Murtaza, Chin‐Ann Johnny Ong, Pierre Lao-Sirieix, Mark Dunning et al. · 2014 · Nature Genetics
Tumor clone dynamics in lethal prostate cancer
Suzanne Carreira, Alessandro Romanel, JANE C. GOODALL, Emily Grist, Roberta Ferraldeschi, Susana Miranda, Davide Prandi, David Lorente, Jean‐Sébastien Frenel, Carmel Jo Pezaro et al. · 2014 · Science Translational Medicine
Residual ctDNA after treatment predicts early relapse in patients with early-stage non-small cell lung cancer
Davina Gillian Gale, Katrin Heider, Andrea Ruiz-Valdepeñas, Sophie Hackinger, M. Perry, Giovanni Marsico, Viona Rundell, Jerome Wulff, G. Sharma, Helena Knock et al. · 2022 · Annals of Oncology
Circulating tumor DNA to monitor treatment response and detect acquired resistance in patients with metastatic melanoma
Elin Solomonovna Gray, Helen Rizos, Anna L. Reid, Suzanah C. Boyd, Michelle R. Pereira, Johnny Lo, Varsha Tembe, James B. Freeman, Jenny Lee, Richard A. Scolyer et al. · 2015 · Oncotarget
Individualized Medicine from Prewomb to Tomb
Eric J. Topol · 2014 · Cell
Breast cancer intra-tumor heterogeneity
Luciano Gastón Martelotto, Charlotte K.Y. Ng, Salvatore Piscuoglio, Britta Weigelt, Jorge Sergio Reis-Filho · 2014 · Breast Cancer Research
Liquid Biopsy: General Concepts
Geoffroy Poulet, Joséphine Massias, Valérie Taly · 2019 · Acta Cytologica
Liquid biopsy in breast cancer: A comprehensive review
Sarah Mirzaie, Maryam Bagherzadeh, Mohammad Reza Akbari · 2019 · Clinical Genetics
Early Detection of Cancer: Past, Present, and Future
Joshua David Schiffman, Paul Graham Fisher, Peter Gibbs · 2015 · American Society of Clinical Oncology Educational Book
Toward the Early Detection of Cancer by Decoding the Epigenetic and Environmental Fingerprints of Cell-Free DNA
Ymke van der Pol, Florent C. Mouliere · 2019 · Cancer Cell
Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics
Ping Song, Lucia Ruojia Wu, Yan Helen Yan, Jinny Xuemeng Zhang, Tianqing Chu, Lawrence N. Kwong, Abhijit A. Patel, David Yu Zhang · 2022 · Nature Biomedical Engineering
Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA
Thompson, Jeffrey C., Yee, Stephanie S., Troxel, Andrea B., Savitch, Samantha L., Fan, Ryan, Balli, David, Lieberman, David B., Morrissette, Jennifer D., Evans, Tracey L., Bauml, Joshua et al. · 2016 · Clinical Cancer Research
Cancer genomics: one cell at a time
Nicholas E. Navin · 2014 · Genome biology
Precision medicine for metastatic breast cancer—limitations and solutions
Mónica Arnedos, Cécile Vicier, Sherene Loi, Céline Lefèbvre, Stefan Michiels, Herve R. Bonnefoi, Fabrice André · 2015 · Nature Reviews Clinical Oncology
Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies
Lena Gorgannezhad, Muhammad Umer, Md. Nazmul Islam, Nam‐Trung Nguyen, Muhammad J. A. Shiddiky · 2018 · Lab on a Chip
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
Bradon R. McDonald, Tania Contente‐Cuomo, Stephen‐John Sammut, Ahuva Odenheimer-Bergman, Brenda J. Ernst, Nieves Perdigones, Suet‐Feung Chin, Maria Farooq, Rosa Mejia, Patricia A. Cronin et al. · 2019 · Science Translational Medicine
Digital Assays Part I: Partitioning Statistics and Digital PCR
Amar S. Basu · 2017 · SLAS TECHNOLOGY
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
Christine Parkinson, Davina Gillian Gale, Anna Piskorz, Heather Biggs, Charlotte Hodgkin, Helen Clare Addley, Sue Freeman, Penelope Moyle, Evis Sala, Karen Sayal et al. · 2016 · PLoS Medicine
Using Circulating Tumor DNA in Colorectal Cancer: Current and Evolving Practices
Midhun Malla, Jonathan M. Loree, Pashtoon Murtaza Kasi, Aparna R. Parikh · 2022 · Journal of Clinical Oncology
Protein analysis of extracellular vesicles to monitor and predict therapeutic response in metastatic breast cancer
Fei Tian, Shaohua Zhang, Chao Liu, Ziwei Han, Yuan Liu, Jinqi Deng, Yike Li, Xia Wu, Lili Cai, Lili Qin et al. · 2021 · Nature Communications
Mutational signatures: emerging concepts, caveats and clinical applications
Ching Chiek Koh, Andrea Degasperi, Xueqing Zou, Sophie Momen, Serena Nik‐Zainal · 2021 · Nature reviews. Cancer
A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma
Reckamp, Karen L., Melnikova, Vladislava O., Karlovich, Chris, Sequist, Lecia V., Camidge, D. Ross, Wakelee, Heather, Perol, Maurice, Oxnard, Geoffrey R., Kosco, Karena, Croucher, Peter et al. · 2016 · Journal of Thoracic Oncology
Patient-centric trials for therapeutic development in precision oncology
Andrew Victor Biankin, Steven Piantadosi, Simon J. Hollingsworth · 2015 · Nature
Emerging concepts in liquid biopsies
Samantha O. Perakis, Michael R. Speicher · 2017 · BMC Medicine
Next-generation sequencing to guide cancer therapy
Jeffrey Gagan, Eliezer M. Van Allen · 2015 · Genome Medicine
Progress in adjuvant systemic therapy for breast cancer
Noam Falbel Ponde, Dimitrios Zardavas, Martine J Piccart · 2018 · Nature Reviews Clinical Oncology
Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
Ira W. Deveson, Binsheng Gong, Kevin Lai, Jennifer S. LoCoco, Todd Richmond, Jeoffrey J. Schageman, Zhihong Zhang, Natalia Novoradovskaya, James C. Willey, Wendell D. Jones et al. · 2021 · Nature Biotechnology
Circulating biomarkers for early detection and clinical management of colorectal cancer
María Marcuello, Veronika Polakova Vymetalkova, Rui P. Neves, Saray Durán-Sanchón, Hege Marie Vedeld, Emma Tham, Guus van Dalum, Georg Flügen, Vanesa García‐Barberán, Remond J.A. Fijneman et al. · 2019 · Molecular Aspects of Medicine
Single-cell mRNA sequencing identifies subclonal heterogeneity in anti-cancer drug responses of lung adenocarcinoma cells
Kyu‐Tae Kim, Hye Won Lee, Hae‐Ock Lee, Sang Cheol Kim, Yun Jee Seo, Woosung Chung, Hye Hyeon Eum, Do‐Hyun Nam, Junhyong Kim, Kyeung Min Joo et al. · 2015 · Genome biology
Clinical Implications of Genomic Discoveries in Lung Cancer
Charles Swanton, Ramaswamy Govindan · 2016 · New England Journal of Medicine
Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection
Clare Fiala, Eleftherios P. Diamandis · 2018 · BMC Medicine
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study
Vincenza Conteduca, Daniel Wetterskog, Mansour Taghavi Azar Sharabiani, Enrique Grande, María Piedad Fernández-Pérez, Anuradha Jayaram, Samanta Salvi, Daniel Castellano, Alessandro Romanel, Cristian Lolli et al. · 2017 · Annals of Oncology
Circulating tumor DNA as a non‐invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types
Ronald Lebofsky, Charles Decraene, Virginie Bernard, Maud T Kamal, Anthony Blin, Quentin Leroy, Thomas Rio Frio, Gaëlle Pierron, Céline Callens, Ivan Bièche et al. · 2014 · Molecular Oncology
Metastasis Dormancy in Estrogen Receptor–Positive Breast Cancer
Xiang H.-F. Zhang, Mario Giuliano, Meghana V. Trivedi, Rachel Schiff, Charles Kent Osborne · 2013 · Clinical Cancer Research
Cancer evolution: Darwin and beyond
Roberto Vendramin, Kevin Litchfield, Charles Swanton · 2021 · The EMBO Journal
Profiling circulating tumour cells and other biomarkers of invasive cancers
Mahla Poudineh, Edward Hartley Sargent, Klaus Pantel, Shana O. Kelley · 2018 · Nature Biomedical Engineering
Circulating tumor DNA as an early cancer detection tool
Andrea Campos-Carrillo, Jeffrey N. Weitzel, Prativa Sahoo, Russell C. Rockne, Janet V. Mokhnatkin, Muhammed Murtaza, Stacy W. Gray, Laura H. Goetz, Ajay Goel, Nicholas J. Schork et al. · 2019 · Pharmacology & Therapeutics
Early Evaluation of Circulating Tumor DNA as Marker of Therapeutic Efficacy in Metastatic Colorectal Cancer Patients (PLACOL Study)
Fanny Garlan, Pierre Laurent‐Puig, David Sefrioui, Nathalie Siauve, Audrey Didelot, Nasrin Sarafan‐Vasseur, Pierre Michel, Géraldine Perkins, Claire Mulot, Hélène Blons et al. · 2017 · Clinical Cancer Research
Non-Invasive Biomarkers for Early Detection of Breast Cancer
Jiawei Li, Xin Guan, Zhimin Fan, Lai‐Ming Ching, Yan Li, Xiaojia Wang, Wen‐Ming Cao, Dong‐Xu Liu · 2020 · Cancers
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
Alessandro Leal, Nicole C.T. van Grieken, Doreen N. Palsgrove, Jillian A. Phallen, Jamie E. Medina, Carolyn Hruban, Mark A. M. Broeckaert, Valsamo Anagnostou, Vilmos Adleff, Daniel C. Bruhm et al. · 2020 · Nature Communications
Quantitative Cell-Free Circulating BRAFV600E Mutation Analysis by Use of Droplet Digital PCR in the Follow-up of Patients with Melanoma Being Treated with BRAF Inhibitors
Miguel F. Sanmamed, Sara F. Landazuri, Carmen Rodríguez, Ruth Zárate, María D. Lozano, Leyre Zubiri, José Luis Perez‐Gracia, Salvador Martín‐Algarra, Álvaro González · 2014 · Clinical Chemistry
Circulating Tumor DNA as Biomarkers for Cancer Detection
Xiao Han, Junyun Wang, Yingli Sun · 2017 · Genomics Proteomics & Bioinformatics
Triple-negative breast cancer: promising prognostic biomarkers currently in development
Jasmine Singh Sukumar, Kelly C. Gast, Dionisia Marie Quiroga, Maryam B. Lustberg, Nicole Olivia Williams · 2020 · Expert Review of Anticancer Therapy
Genomic Medicine: A Decade of Successes, Challenges, and Opportunities
Jeanette J. McCarthy, Howard L. McLeod, Geoffrey S. Ginsburg · 2013 · Science Translational Medicine
Detection of K‐ras gene mutation by liquid biopsy in patients with pancreatic cancer
Kinugasa, Hideaki, Nouso, Kazuhiro, Miyahara, Koji, Morimoto, Yuki, Dohi, Chihiro, Tsutsumi, Koichiro, Kato, Hironari, Matsubara, Takehiro, Okada, Hiroyuki, Yamamoto, Kazuhide · 2015 · Cancer
Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab
Rajiv G. Raja, Michael A. Kuziora, Philip Z. Brohawn, Brandon W. Higgs, Ashok Kumar Gupta, Phillip A. Dennis, Koustubh Ranade · 2018 · Clinical Cancer Research
The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients
Yahya Elshimali, Husseina Khaddour, Marianna Sarkissyan, Yanyuan Wu, Jaydutt V. Vadgama · 2013 · International Journal of Molecular Sciences
Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study
Yao Wang, Mei Yu Chen, Xiao Nan, Hui Liu · 2016 · Gene
Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer
Françoise Rothé, Jean‐François Laes, Diether Lambrechts, D. Smeets, D. Vincent, Marion Maetens, Debora Fumagalli, Stefan Michiels, Stylianos Drisis, Carine Moerman et al. · 2014 · Annals of Oncology
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma
María Romina Girotti, Gabriela Gremel, Rebecca J. Lee, Elena Galvani, Dominic G. Rothwell, Amaya Virós, Amit Kumar Mandal, Kok Haw Jonathan Lim, Grazia Saturno, Simon J. Furney et al. · 2015 · Cancer Discovery
Multi‐marker analysis of circulating cell‐free DNA toward personalized medicine for colorectal cancer
Florent C. Mouliere, Safia El Messaoudi, Dalong Pang, Anatoly Dritschilo, Alain Roger Thierry · 2014 · Molecular Oncology
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Daniel G. Stover, Heather Anne Parsons, Gavin Ha, Samuel S. Freeman, William Thomas Barry, Hao Guo, Atish Dipankar Choudhury, Gregory Gydush, Sarah C. Reed, Justin Rhoades et al. · 2018 · Journal of Clinical Oncology
Liquid Biopsy for Cancer: Circulating Tumor Cells, Circulating Free DNA or Exosomes?
Wei Zhang, Wenjie Xia, Zhengye Lv, Chao Ni, Xin Yin, Liu Yang · 2017 · Cellular Physiology and Biochemistry
Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA
Hai Zemmour, David Planer, Judith Magenheim, Joshua Moss, Daniel Neiman, Dan Gilon, Amit Korach, Benjamin Gläser, Ruth Shemer, Giora Landesberg et al. · 2018 · Nature Communications
Clinical cancer genomic profiling
Debyani Chakravarty, David B. Solit · 2021 · Nature Reviews Genetics
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker, Geoffrey R. Oxnard, Carolyn C. Compton, Maximilian Diehn, Patricia A. Hurley, Alexander J. Lazar, Neal Ian Lindeman, Christina M. Lockwood, Alex J. Rai, Richard L. Schilsky et al. · 2018 · Archives of Pathology & Laboratory Medicine
Towards Multidrug Adaptive Therapy
Jeffrey West, Li You, Jingsong Zhang, Robert A. Gatenby, Joel S. Brown, Paul K. Newton, Alexander R.A. Anderson · 2020 · Cancer Research
Identification of Developmental Endothelial Locus-1 on Circulating Extracellular Vesicles as a Novel Biomarker for Early Breast Cancer Detection
Pyong‐Gon Moon, Jeong‐Eun Lee, Young‐Eun Cho, Soo Jung Lee, Jin Hyang Jung, Yee Soo Chae, Han‐Ik Bae, Young‐Bum Kim, In‐San Kim, Ho Yong Park et al. · 2015 · Clinical Cancer Research
Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts
Jacqui Shaw, David S. Guttery, Allison Hills, Daniel Fernández-García, Karen Page, Brenda Maria Rosales, Kate S. Goddard, Robert K. Hastings, Jinli Luo, Olivia Ogle et al. · 2016 · Clinical Cancer Research
Pathways and therapeutic targets in melanoma
Emma Shtivelman, Michael A. Davies, Patrick Hwu, James Chih-Hsin Yang, Michal Lotem, Moshe Oren, Keith T. Flaherty, David E. Fisher · 2014 · Oncotarget
Circulating tumor DNA analysis as a real-time method for monitoring tumor burden in melanoma patients undergoing treatment with immune checkpoint blockade
Evan J. Lipson, Victor E. Velculescu, Theresa S. Pritchard, Mark Sausen, Drew M. Pardoll, Suzanne Louise Topalian, Luis Alberto Diaz · 2014 · Journal for ImmunoTherapy of Cancer
Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical Validation
John B. Kisiel, Brian A. Dukek, Reddappa V.S.R. Kanipakam, Hassan M. Ghoz, Tracy C. Yab, Calise K. Berger, William R. Taylor, Patrick H. Foote, Nasra H. Giama, Kristeen Onyirioha et al. · 2018 · Hepatology
Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002
Couraud, Sébastien, Vaca-Paniagua, Felipe, Villar, Stéphanie, Oliver, Javier, Schuster, Tibor, Blanché, Hélène, Girard, Nicolas, Trédaniel, Jean, Guilleminault, Laurent, Gervais, Radj et al. · 2014 · Clinical Cancer Research
Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
Vincent P. Groot, Stacy L. Mosier, Ammar A. Javed, Jonathan A. Teinor, Georgios Gemenetzis, Ding Ding, Lisa M. Haley, Jun Yu, Richard Andrew Burkhart, Alina Hasanain et al. · 2019 · Clinical Cancer Research
Synthetic biomarkers: a twenty-first century path to early cancer detection
Gabriel A. Kwong, Sharmistha Ghosh, Lena Gamboa, Christos Patriotis, Sudhir Srivastava, Sangeeta N. Bhatia · 2021 · Nature reviews. Cancer
A field guide for cancer diagnostics using cell‐free DNA: From principles to practice and clinical applications
Anna‐Lena Volckmar, Holger Sültmann, Anja Lisa Riediger, Thoas Fioretos, Peter Schirmacher, Volker Endris, Albrecht Stenzinger, Steffen Dietz · 2017 · Genes Chromosomes and Cancer
Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials
Ademi Santiago-Walker, Robert Gagnon, Jolly Mazumdar, Michelle Casey, Georgina Venetia Long, Dirk Schadendorf, Keith T. Flaherty, Richard F. Kefford, Axel Hauschild, Patrick Hwu et al. · 2015 · Clinical Cancer Research
Advances in the treatment of advanced oestrogen-receptor-positive breast cancer
Turner, Nicholas C, Neven, Patrick, Loibl, Sibylle, Andre, Fabrice · 2017 · The Lancet
Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
Rishu Agarwal, Yih-Chih Chan, Constantine Si Lun Tam, Tane Hunter, Dane Vassiliadis, Charis E. Teh, Rachel Thijssen, Paul Sung-Hao Yeh, Stephen Q. Wong, Sarah Ftouni et al. · 2018 · Nature Medicine
A carbon nanotube reporter of microRNA hybridization events in vivo
Jackson Dean Harvey, Prakrit Vaibhav Jena, Hanan A. Baker, Gül H. Zerze, Ryan M. Williams, Thomas Vito Galassi, Daniel Roxbury, Jeetain Mittal, Daniel A. Heller · 2017 · Nature Biomedical Engineering
Circulating tumor DNA analysis depicts subclonal architecture and genomic evolution of small cell lung cancer
Jingying Nong, Yuhua Gong, Yanfang Guan, Xin Yi, Yuting Yi, Lianpeng Chang, Ling Yang, Jialin Lv, Zhirong Guo, Hongyan Jia et al. · 2018 · Nature Communications
Detection and isolation of circulating exosomes and microvesicles for cancer monitoring and diagnostics using micro-/nano-based devices
Jina Ko, Erica L. Carpenter, David Issadore · 2015 · The Analyst
Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
Peilu Wang, Amir Bahreini, Rekha Gyanchandani, Peter C. Lucas, Ryan James Hartmaier, Rebecca Jean Watters, Amruth R. Jonnalagadda, Humberto E. Trejo Bittar, Aaron Berg, Ronald L. Hamilton et al. · 2015 · Clinical Cancer Research
Analytical Validation of a Hybrid Capture–Based Next-Generation Sequencing Clinical Assay for Genomic Profiling of Cell-Free Circulating Tumor DNA
Clark, Travis A., Chung, Jon H., Kennedy, Mark, Hughes, Jason D., Chennagiri, Niru, Lieber, Daniel S., Fendler, Bernard, Young, Lauren, Zhao, Mandy, Coyne, Michael et al. · 2018 · The Journal of Molecular Diagnostics
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
Peneder, Peter, Stütz, Adrian M., Surdez, Didier, Krumbholz, Manuela, Semper, Sabine, Chicard, Mathieu, Sheffield, Nathan C., Pierron, Gaelle, Lapouble, Eve, Tötzl, Marcus et al. · 2021 · Nature Communications
Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer
Kaijiong Zhang, Zhenglian Luo, Yi Zhang, Li Zhang, Lichun Wu, Lian Liu, Jie Yang, Xiaoyu Song, Jinbo Liu · 2016 · Cancer Biomarkers
Cell-free DNA analysis in current cancer clinical trials: a review
Mireya Cisneros-Villanueva, Lizbett Hidalgo Pérez, Magdalena Ríos-Romero, Alberto Cedro‐Tanda, C. A. Ruiz-Villavicencio, K. Page, Robert K. Hastings, Daniel Fernández-García, Rebecca C. Allsopp, Marco Antonio Fonseca-Montaño et al. · 2022 · British Journal of Cancer
Circulating tumor cells in breast cancer
François‐Clément Bidard, Charlotte Proudhon, Jean‐Yves Pierga · 2016 · Molecular Oncology
Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy
Luc Cabel, Charlotte Proudhon, Emanuela Romano, Nicolas Girard, Olivier J Lantz, Marc‐Henri Stern, Jean‐Yves Pierga, François‐Clément Bidard · 2018 · Nature Reviews Clinical Oncology
Circulating tumor cells: Advances in isolation and analysis, and challenges for clinical applications
Ramdane A Harouaka, Zhigang Kang, Si-Yang Zheng, Liang Cao · 2013 · Pharmacology & Therapeutics
ctDNA monitoring using patient-specific sequencing and integration of variant reads
Jonathan C. M. Wan, Katrin Heider, Davina Gillian Gale, Suzanne Murphy, Eyal Fisher, Florent C. Mouliere, Andrea Ruiz-Valdepeñas, Ángela Santonja, James Morris, Dineika Chandrananda et al. · 2020 · Science Translational Medicine
Monitoring of epidermal growth factor receptor tyrosine kinase inhibitor‐sensitizing and resistance mutations in the plasma DNA of patients with advanced non–small cell lung cancer during treatment with erlotinib
Boe Sandahl Sørensen, Lin Wu, Wen Wei, Julie Tsai, Britta Weber, Ebba Nexø, Peter Meldgaard · 2014 · Cancer
Imaging Metabolism with Hyperpolarized 13C-Labeled Cell Substrates
Kevin Michael Brindle · 2015 · Journal of the American Chemical Society
Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges
Enrique Sanz‐García, Eric Y. Stutheit-Zhao, Scott Victor Bratman, Lillian L. Siu · 2022 · Science Advances
Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer
Lynnette Fernandez‐Cuesta, Sandra P. Perdomo, Patrice Hodonou Avogbe, Noémie Leblay, Tiffany Myriam Delhomme, Valérie Gaborieau, Behnoush Abedi‐Ardekani, Estelle Chanudet, Magali Olivier, David Georgievich Zaridze et al. · 2016 · EBioMedicine
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
Chin, Re-I, Chen, Kevin, Usmani, Abul, Chua, Chanelle, Harris, Peter K., Binkley, Michael S., Azad, Tej D., Dudley, Jonathan C., Chaudhuri, Aadel A. · 2019 · Molecular Diagnosis & Therapy
Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non–Small Cell Lung Cancer: A Meta-analysis
Mantang Qiu, Jie Wang, Youtao Xu, Xiangxiang Ding, Ming Li, Feng Jiang, Lin Xu, Rong H. Yin · 2014 · Cancer Epidemiology Biomarkers & Prevention
Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy
Simeon U. Springer, Chung‐Hsin Chen, Maria Del Carmen Rodriguez Peña, Lu Li, Christopher Blair Douville, Yuxuan Wang, Joshua David Cohen, Diana Taheri, Natalie Silliman, Joy Schaefer et al. · 2018 · eLife
Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration
Jean‐Sébastien Frenel, Suzanne Carreira, JANE C. GOODALL, Desam Roda, Raquel Pérez-López, Nina Tunariu, Ruth Riisnaes, Susana Miranda, Ines Figueiredo, Daniel Nava Rodrigues et al. · 2015 · Clinical Cancer Research
Molecular heterogeneity in breast cancer: State of the science and implications for patient care
Rachel E. Ellsworth, Heather L. Blackburn, Craig D. Shriver, Patrick Soon‐Shiong, Darrell L. Ellsworth · 2016 · Seminars in Cell and Developmental Biology
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications
Boire, Adrienne, Brandsma, Dieta, Brastianos, Priscilla K, Le Rhun, Emilie, Ahluwalia, Manmeet, Junck, Larry, Glantz, Michael, Groves, Morris D, Lee, Eudocia Q, Lin, Nancy et al. · 2019 · Neuro-Oncology
Liquid biopsies in lung cancer: The new ambrosia of researchers
Christian D. Rolfo, Marta Castiglia, David S. Hong, Riccardo Alessandro, Inge Mertens, Geert Baggerman, Karen Zwaenepoel, Ignacio Gil Bazo, Francesco Passiglia, Anna Paola Carreca et al. · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers
Elena B. Pereira, Olga Camacho‐Vanegas, Sanya Anand, Robert Sebra, Sandra Catalina Camacho, Leopold Garnar-Wortzel, Navya Nair, Erin L Moshier, Melissa Wooten, Andrew V. Uzilov et al. · 2015 · PLoS ONE
The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA
Sonya T. Parpart-Li, Bjarne R. Bartlett, Maria Popoli, Vilmos Adleff, Laura Tucker, Rebecca Steinberg, Andrew P. Georgiadis, Jill Phallen, Julie Renee Brahmer, Nilo A. Azad et al. · 2016 · Clinical Cancer Research
Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)
Chris Karlovich, Jonathan Wade Goldman, Jong‐Mu Sun, Elaina Mann, Lecia Van Dam Sequist, Krzysztof Konopa, Wei Wen, Philipp Angenendt, Leora Horn, David Robert Spigel et al. · 2016 · Clinical Cancer Research
Digital PCR analysis of circulating nucleic acids
Irena Hudecova · 2015 · Clinical Biochemistry
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
Kristina Warton, Kate Lynette Mahon, Goli Samimi · 2016 · Endocrine Related Cancer
Circulating tumour cells and cell-free DNA as tools for managing breast cancer
Leticia De Mattos‐Arruda, Javier Cortés, Libero Santarpia, Ana P. Vivancos, Josep M. Tabernero, Jorge Sergio Reis-Filho, Joan Seoane · 2013 · Nature Reviews Clinical Oncology
Development of a highly sensitive liquid biopsy platform to detect clinically-relevant cancer mutations at low allele fractions in cell-free DNA
Davina Gillian Gale, Andrew R. J. Lawson, Karen Howarth, Mikidache Madi, Bradley Durham, Sarah Smalley, John D. Calaway, Shannon Blais, Greg Jones, James Clark et al. · 2018 · PLoS ONE